Search - Prime Therapeutics
Navigate to
-
Eyebrow High-Cost Therapy Profile: February Detailed information about Marnetegragene autotemcel Intravenous (IV) High Cost Therapy Profile Gene Therapy/Immunology Marnetegragene autotemcel...
-
publications Optimizing immunoglobulin use in multiple myeloma: clinical and managed care perspectives September 19, 2025 Author: Abby Kim, PharmD, BCOP Multiple myeloma (MM) is a hematologic...
-
Prime works to simplify medication management and support patients with migraine, making migraine treatment less of a pain point
Prime Article: Stories -
Managed Markets Insight & Technology (MMIT)
PA Sub-Categories: Specialty drugs Products Prime Article: In the News -
publications BiTEs and roadblocks June 25, 2025 Author: Simone Ndujiuba, PharmD, BCOP US Food and Drug Administration (FDA) has approved fourteen bispecific antibody drugs to treat a variety of...
-
Ben Urick, senior director of health outcomes, and Landon Marshall, health outcomes research principal, share more about their educational session and research poster on GLP-1s
PA Sub-Categories: GLP-1 Prime Article: Perspectives -
Breadcrumb Home Newsroom Custom Content Prime Careers Spotlight Prime Careers Spotlight: September 2025 Prime Careers Spotlight: September 2025 Check out our latest job openings. Together, we can...
-
publications Innovations Driving the Future of Breast Cancer Care October 21, 2025 Author: Abby Kim, PharmD, BCOP October marks Breast Cancer Awareness Month - a time to spotlight innovations...
-
Prime/MRx remains at the forefront of GLP-1 research, presenting weight loss studies at this year’s annual meeting.
PA Sub-Categories: GLP-1 Specialty drugs Products Prime Article: Press Releases -
Read Clinical News: August 2024 Your monthly source for drug information highlights Clinical News Your monthly source for drug information highlights Hot topics FDA SAFETY ALERT ON COMPOUNDED...